Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia

Condition:   Congenital Adrenal Hyperplasia Interventions:   Drug: Crinecerfont;   Drug: Placebo Sponsor:   Neurocrine Biosciences Not yet recruiting

Source: ClinicalTrials.gov - July 29, 2020 Category: Research Source Type: clinical trials